NASDAQ:DXCM

DexCom - DXCM Earnings Date, Estimates & Call Transcripts

$116.07

+1.98 (+1.74%)

(As of 03/27/2023 12:00 AM ET)

Add

Compare

Today's Range: $115.04
▼
$117.95
50-Day Range: $104.00
▼
$122.92
52-Week Range: $66.89
▼
$134.76

Volume: 1.57 million shs
Average Volume: 2.55 million shs
Market Capitalization: $44.85 billion

P/E Ratio: 142.86
Dividend Yield: N/A
Price Target: $123.00

Institutional Ownership

Upcoming Earnings Date: Apr. 27Estimated
Actual EPS (Feb. 9): $0.34 Beat By $0.08
Consensus EPS (Feb. 9): $0.26
Last Year's Q1 EPS (2/10/2022): $0.17

Read Call Transcript

Listen to Call

Latest SEC 10-Q Filing

Earnings Per Share Revenue

DXCM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

DXCM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

DexCom Analyst Forecasts

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate	Company Guidance
Q1 2023	4	$0.10	$1.01	$0.51
Q2 2023	4	$0.19	$1.17	$0.61
Q3 2023	4	$0.31	$1.39	$0.78
Q4 2023	4	$0.33	$1.71	$0.91
FY 2023	16	$0.93	$5.28	$2.80
Q1 2024	1	$0.21	$0.21	$0.21
Q2 2024	1	$0.30	$0.30	$0.30
Q3 2024	1	$0.40	$0.40	$0.40
Q4 2024	1	$0.44	$0.44	$0.44
FY 2024	4	$1.35	$1.35		$1.35

DXCM Earnings Date and Information

DexCom last issued its earnings results on February 9th, 2023. The medical device company reported $0.34 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.26 by $0.08. The business had revenue of $815.20 million for the quarter, compared to analysts' expectations of $814.52 million. Its revenue was up 16.8% compared to the same quarter last year. DexCom has generated $0.81 earnings per share over the last year ($0.81 diluted earnings per share) and currently has a price-to-earnings ratio of 142.9. Earnings for DexCom are expected to grow by 35.51% in the coming year, from $1.07 to $1.45 per share. DexCom has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 27th, 2023 based off prior year's report dates.

DexCom Earnings History by Quarter

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
4/27/2023 (Estimated)
2/9/2023	Q4 2022	$0.26	$0.34	+$0.08	$0.46	$814.52 million	$815.20 million
10/27/2022	Q3 2022	$0.24	$0.28	+$0.04	$0.32	$752.67 million	$769.60 million
7/28/2022	Q2 2022	$0.17	$0.17		$0.22	$709.33 million	$696.20 million
4/28/2022	Q1 2022	$0.1250	$0.08	($0.0450)	($0.29)	$623.97 million	$628.80 million
2/10/2022	Q4 2021	$0.2150	$0.17	($0.0450)	$1.56	$698.66 million	$698.20 million
10/28/2021	9/30/2021	$0.1550	$0.2225	+$0.0675	$1.07	$617.07 million	$650.20 million

7/29/2021	6/30/2021	$0.1075	$0.19	+$0.0825	$0.89	$548.02 million	$595.10 million
4/29/2021	3/31/2021	$0.0775	$0.0825	+$0.0050	$0.25	$482.67 million	$505.00 million
2/11/2021	12/31/2020	$0.2275	$0.2275		($1.66)	$558.41 million	$568.90 million
10/27/2020	9/30/2020	$0.16	$0.2350	+$0.0750	$1.15	$477.22 million	$500.90 million
7/28/2020	6/30/2020	$0.0775	$0.1975	+$0.12	$1.10	$415.21 million	$451.80 million
4/28/2020	3/31/2020	$0.0375	$0.11	+$0.0725	$0.67	$358.34 million	$405.10 million
2/13/2020	Q4 2019	$0.1850	$0.2875	+$0.1025	$1.30	$457.00 million	$462.80 million
11/6/2019	Q3 2019	$0.05	$0.1625	+$0.1125	$0.80	$348.99 million	$396.30 million
7/31/2019	Q2	$0.0033	$0.02	+$0.0168	$0.28	$304.40 million	$336.40 million
5/1/2019	Q1 2019	($0.0425)	($0.0125)	+$0.03	$0.20	$246.10 million	$280.50 million
2/21/2019	12/31/2018	$0.04	$0.1350	+$0.0950	$3.11	$331.60 million	$338.00 million
11/6/2018	9/30/2018	($0.03)	$0.0425	+$0.0725	($0.18)	$242.72 million	$266.70 million
8/1/2018	Q2 2018	($0.0450)	($0.0250)	+$0.02	($0.54)	$205.81 million	$242.50 million
5/2/2018	Q1 2018	($0.08)	($0.08)		($0.36)	$172.66 million	$184.40 million
2/27/2018	Q4 2017	$0.0075	$0.0250	+$0.0175	$0.31	$217.82 million	$221.00 million
11/1/2017	Q3 2017	($0.0375)	($0.01)	+$0.0275	($0.06)	$183.42 million	$184.60 million
8/1/2017	Q2 2017	($0.0575)	($0.04)	+$0.0175	($0.35)	$166.54 million	$170.60 million
5/2/2017	Q1 2017	($0.1375)	($0.1225)	+$0.0150	($0.49)	$143.94 million	$142.30 million
2/28/2017	Q416	($0.0250)	($0.0225)	+$0.0025	($0.09)	$167.51 million	$171.20 million
11/1/2016	Q316	($0.0350)	($0.0550)	($0.02)	($0.22)	$146.09 million	$148.60 million
8/2/2016	Q216	($0.03)	($0.06)	($0.03)	($0.24)	$132.48 million	$137.30 million
4/27/2016	Q116	($0.05)	($0.0575)	($0.0075)	($0.23)	$110.37 million	$116.20 million
2/23/2016	Q415	$0.0025	$0.0050	+$0.0025	$0.02	$122.93 million	$130.80 million
11/4/2015	Q315	($0.0025)	($0.0175)	($0.0150)	$0.39	$97.47 million	$105.20 million
8/5/2015	Q215	($0.0075)	($0.0125)	($0.0050)	($0.05)	$84.74 million	$93.20 million
4/29/2015	Q115	($0.0275)	($0.0425)	($0.0150)	($0.17)	$71.32 million	$72.80 million
2/25/2015	Q414	($0.0075)	$0.0050	+$0.0125	$0.02	$79.65 million	$84.30 million
11/6/2014	Q314	($0.0125)	($0.02)	($0.0075)	($0.08)	$60.20 million	$67.90 million
8/6/2014	Q214	($0.0250)	($0.0250)		($0.11)	$52.45 million	$58.80 million
5/1/2014	Q114	($0.02)	($0.0425)	($0.0225)	($0.17)	$44.15 million	$47.10 million
2/20/2014	Q4 2013	($0.0175)	($0.01)	+$0.0075	($0.04)	$48.53 million	$51.30 million
11/6/2013	Q3 2013	($0.0325)	($0.02)	+$0.0125	($0.08)	$35.90 million	$42.90 million
8/7/2013	Q2 2013	($0.04)	($0.0350)	+$0.0050	($0.14)	$31.14 million	$35.80 million
5/1/2013	Q1 2013	($0.0425)	($0.04)	+$0.0025	($0.16)	$28.26 million	$29.60 million

2/21/2013	Q4 2012	($0.0375)	($0.03)	+$0.0075		$31.09 million	$33.30 million
11/1/2012	Q312	($0.0550)	($0.0625)	($0.0075)		$23.14 million	$23.10 million
8/6/2012		($0.05)	($0.0525)	($0.0025)
5/2/2012		($0.0475)	($0.0525)	($0.0050)
2/23/2012		($0.0425)	($0.0450)	($0.0025)
11/2/2011		($0.0375)	($0.05)	($0.0125)
8/3/2011		($0.0275)	($0.0275)
5/3/2011		($0.0475)	($0.0475)
3/3/2011		($0.0475)	($0.04)	+$0.0075
11/4/2010	Q3 2010	($0.0425)	($0.0575)	($0.0150)	($0.23)
8/3/2010	Q2 2010	($0.05)	($0.05)		($0.20)
5/5/2010	Q1 2010	($0.06)	($0.0675)	($0.0075)	($0.14)
3/9/2010	Q4 2009	($0.0675)	($0.0625)	+$0.0050	($0.25)
11/4/2009	Q3 2009	($0.08)	($0.0725)	+$0.0075	($0.29)
8/3/2009	Q2 2009	($0.0725)	($0.0825)	($0.01)	($0.33)
5/6/2009	Q1 2009	($0.08)	($0.0750)	+$0.0050	($0.27)
3/5/2009	Q4 2008	($0.11)	($0.1125)	($0.0025)	($0.45)
11/10/2008	Q3 2008	($0.1150)	($0.1250)	($0.01)	($0.50)
8/5/2008	Q2 2008	($0.1150)	($0.12)	($0.0050)	($0.48)
5/8/2008	Q1 2008	($0.0975)	($0.11)	($0.0125)	($0.44)
3/11/2008	Q4 2007	($0.1025)	($0.1075)	($0.0050)	($0.43)

DexCom Earnings - Frequently Asked Questions

When is DexCom's earnings date?: DexCom has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 27th, 2023 based off last year's report dates. Learn more on DXCM's earnings history.
Did DexCom beat their earnings estimates last quarter?: In the previous quarter, DexCom (NASDAQ:DXCM) reported $0.34 earnings per share (EPS) to beat the analysts' consensus estimate of $0.26 by $0.08. Learn more on analysts' earnings estimate vs. DXCM's actual earnings.
How can I listen to DexCom's earnings conference call?: The conference call for DexCom's latest earnings report can be listened to online. Listen to Conference Call
How can I read DexCom's conference call transcript?: The conference call transcript for DexCom's latest earnings report can be read online. Read Transcript
How can I view DexCom's earnings report?: DexCom's earnings report can be found in their filing with the SEC. View SEC filing

How much revenue does DexCom generate each year?: DexCom (NASDAQ:DXCM) has a recorded annual revenue of $2.91 billion.
How much profit does DexCom generate each year?: DexCom (NASDAQ:DXCM) has a recorded net income of $341.20 million. DXCM has generated $0.81 earnings per share over the last four quarters.
What is DexCom's price-to-earnings ratio?: DexCom (NASDAQ:DXCM) has a trailing price-to-earnings ratio of 142.86 and a forward price-to-earnings ratio of 108.48. The price/earnings-to-growth ratio is 2.74.
What is DexCom's EPS forecast for next year?: DexCom's earnings are expected to grow from $1.07 per share to $1.45 per share in the next year, which is a 35.51% increase.

More Earnings Resources from MarketBeat

Earnings Tools:

Earnings By Country:

Latest Articles:

Upcoming Earnings:

Infosys (4/12/2023)
BlackRock (4/12/2023)
U.S. Bancorp (4/13/2023)
Wells Fargo & Company (4/13/2023)
Taiwan Semiconductor Manufacturing (4/13/2023)
Progressive (4/13/2023)
Citigroup (4/14/2023)
JPMorgan Chase & Co. (4/14/2023)
UnitedHealth Group (4/14/2023)
Charles Schwab (4/17/2023)

This page (NASDAQ:DXCM) was last updated on 3/28/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

DexCom - DXCM Earnings Date, Estimates & Call Transcripts

DXCM Earnings Estimates and Actuals by Quarter

DXCM Estimated and Actual Revenue by Quarter

DexCom Analyst Forecasts

DXCM Earnings Date and Information

DexCom Earnings History by Quarter

DexCom Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info

DexCom - DXCM Earnings Date, Estimates & Call Transcripts

Earnings Summary

DXCM Earnings Estimates and Actuals by Quarter

DXCM Estimated and Actual Revenue by Quarter

DexCom Analyst Forecasts

DXCM Earnings Date and Information

DexCom Earnings History by Quarter

DexCom Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat